We recently compiled a list of the 14 Worst 52-Week High Stocks to Buy According to Short Sellers. In this article, we are ...

Most readers would already be aware that TG Therapeutics' (NASDAQ:TGTX) stock increased significantly by 49% over ...

TG Therapeutics, Inc. (NASDAQ:TGTX) stock is trading higher on Wednesday after the company announced it updated its data ...

As of the latest trading close, TGTX, a Healthcare sector stock, is trading -3.15% below its 52-week high but remains 285.29% above its 52-week low. The Average True Range (ATR) (14 days) of 1.42 ...

TG Therapeutics Inc common stock (TGTX) stock saw a modest uptick, ending the day at $23.19 which represents a slight increase of $0.12 or 0.52% from the prior close of $23.07. The stock opened at $22 ...

TG Therapeutics (TGTX) In a report released yesterday ... In a report issued on September 4, Raymond James also maintained a Buy rating on the stock with a $94.00 price target. Boston Scientific ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Investors in TG Therapeutics Inc (Symbol: TGTX) saw new options begin trading today, for the November 1st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

Check the time stamp on this data. Updated AI-Generated Signals for Tg Therapeutics Inc. (TGTX) available here: TGTX.

TG Therapeutics (TGTX) presented updated data from the ENHANCE Phase 3b trial evaluating BRIUMVI in patients with relapsing forms of ...

TG Therapeutics, Inc. TGTX stock is trading higher on Wednesday after the company announced it updated its data presentations to include details from the ULTIMATE I & II Phase 3 trials ...